BRCA1 and breast carcinoma: In addition, the investigation of multiple mutants of BRCA1 from patients that disrupt the interaction of E2 enzymes without perturbing the BRCA1–BARD1 complex has revealed that E3 ligase activity strongly correlates with BRCA1 functions in HR, and breast cancer susceptibility [77,94].